向与运动相关的基因和胎盘生长因子,用于头部和部状细胞癌的治疗发展
Qingyuan Shi1, Haiyue Ying1, Weibin Weng1
1Ningbo NO.2 hospital, Ningbo, China.
Frontiers in pharmacology
|October 21, 2024
概括
这项研究确定了与运动相关的基因,包括胎盘生长因子 (PIGF),作为头部和部状细胞癌 (HNSCC) 的关键预后生物标志物. 准PIGF对创新的癌症疗法和个性化医学有很大的希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 头部和部状细胞癌 (HNSCC) 是一种由不受控制的细胞生长驱动的复杂癌症.
- 翻译后修改 (PTM) 在癌症进展中至关重要,并代表潜在的治疗点.
- 识别预后生物标志物对于有效的HNSCC治疗策略至关重要.
研究的目的:
- 在HNSCC中使用生物信息学识别具有预后价值的与运动相关的基因.
- 调查胎盘生长因子 (PIGF) 在HNSCC中的治疗潜力.
- 探索PIGF在瘤生长和瘤微环境中的作用.
主要方法:
- 对HNSCC的癌症基因组图谱 (TCGA) 转录组数据的分析.
- 差异表达基因 (DEGs) 的鉴定和预后评估.
- 功能丰富分析 (GO,KEGG,GSEA) 和体外实验.
主要成果:
- 确定了与HNSCC生存预后相关的与运动相关的基因.
- 胎盘生长因子 (PIGF) 显示出诊断潜力,并与晚期瘤阶段有关.
- 实验室研究证实,PIGF增强了HNSCC细胞的增殖和殖民地形成.
结论:
- 与运动相关的基因,特别是PIGF,是HNSCC临床治疗的有希望的生物标志物.
- 针对PIGF的向提出了针对头癌的创新治疗策略.
- 这些发现支持PIGF在瘤生长调节中的作用和个性化医学的潜力.
更多相关视频
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.1K
12:03Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma
Published on: July 25, 2011
19.2K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
